Ciba-Geigy's Lopressor
Executive Summary
Firm reported in its inhouse newsletter PhamaNewL that sales of the antihypertensive were up 28% in 1984 and through April 1985 increased 43.3%. Ciba-Geigy attributes growth to change in marketing strategy, more competitive promotion spending and support from sales and other departments. N Ciba-Geigy attributes growth to change in marketing strategy, more competitive promotion spending and support from sales and other departments.